Distalmotion announces successful completion of cadaver study, confirming Dexter’s core value proposition of removing complexity out of robotic surgery to fast track its adoption in minimally invasive surgical care

Major milestone towards go-to market for Distalmotion’s surgical robot Dexter

Lausanne, Switzerland, 29 August 2019: Distalmotion, a Swiss-based medical device company removing the complexity out of robotic surgery to fast track its widespread adoption in minimally invasive surgical care, announced today the successful completion of its latest cadaver study involving Dexter, its surgical robot developed and manufactured in Switzerland. Combining the affordability of laparoscopy with the benefits of robotic solutions, Dexter pioneers simplicity and versatility in the market for minimally invasive surgical care.